Determination of daidzein in human plasma by high performance liquid chromatography tandem mass spectrometry

YANG Bin,SU Meng-xiang,DI Bin,WU Chun-yong
DOI: https://doi.org/10.3969/j.issn.1007-7669.2007.05.010
2007-01-01
Abstract:AIM:To determine the concentration of daidzein in human plasma with LC-MS-MS method for pharmacokinetics study and bioequivalence evaluation.METHODS:A Merck LiChroCART C_(18)HPLC column was used in the method with luteolin as internal standard and methanol as protein precipitation (containing 0.2% acetic acid).Quantitation was accomplished by LC-MS-MS method in the selective reaction monitoring mode based on negative ion electrospray ionization(ESI).The selected ion monitoring was negative ion.Daidzein at m/z 252.9 and luteolin at m/z 284.8 was chosen as the analytical ion.RESULTS:Impurities in plasma didn't interfere the determination of daidzein and luteolin by the method.The calibration curve was linear over a concentration range of 0.1004-80.32μg·L~(-1)(r=0.994 0).The absolute recoveries of daidzein in plasma were more than 80%.The intra-day and inter-day RSD of QC samples were less than 10% at 0.4016, 4.016 and 40.16μg·L~(-1).CONCLUSION:The method is accurate and sensitive in the determination of daidzein for pharmacokinetics and bioequivalence evaluation.
What problem does this paper attempt to address?